SG Americas Securities LLC grew its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 11.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 28,325 shares of the company’s stock after acquiring an additional 2,925 shares during the quarter. SG Americas Securities LLC’s holdings in AmerisourceBergen were worth $2,107,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in the business. Private Capital Group LLC increased its holdings in shares of AmerisourceBergen by 201.3% in the fourth quarter. Private Capital Group LLC now owns 482 shares of the company’s stock worth $36,000 after purchasing an additional 322 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its stake in shares of AmerisourceBergen by 140.9% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,142 shares of the company’s stock valued at $105,000 after buying an additional 668 shares during the last quarter. Financial Gravity Wealth Inc. grew its stake in shares of AmerisourceBergen by 93.2% during the third quarter. Financial Gravity Wealth Inc. now owns 1,254 shares of the company’s stock valued at $108,000 after buying an additional 605 shares during the last quarter. Ipswich Investment Management Co. Inc. bought a new position in shares of AmerisourceBergen during the fourth quarter valued at approximately $96,000. Finally, Truvestments Capital LLC purchased a new stake in shares of AmerisourceBergen in the third quarter valued at approximately $120,000. 68.51% of the stock is owned by hedge funds and other institutional investors.
NYSE ABC opened at $83.64 on Tuesday. AmerisourceBergen Corp. has a one year low of $69.36 and a one year high of $102.00. The company has a current ratio of 0.94, a quick ratio of 0.53 and a debt-to-equity ratio of 1.43. The firm has a market capitalization of $17.66 billion, a price-to-earnings ratio of 12.89, a price-to-earnings-growth ratio of 1.55 and a beta of 1.12.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 4th. Investors of record on Tuesday, February 19th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.91%. The ex-dividend date of this dividend is Friday, February 15th. AmerisourceBergen’s payout ratio is 24.65%.
In other news, CEO Steven H. Collis sold 21,350 shares of the stock in a transaction on Wednesday, January 2nd. The shares were sold at an average price of $73.96, for a total value of $1,579,046.00. Following the completion of the sale, the chief executive officer now owns 155,929 shares of the company’s stock, valued at $11,532,508.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Dale Danilewitz sold 5,703 shares of the stock in a transaction on Thursday, February 7th. The stock was sold at an average price of $86.80, for a total transaction of $495,020.40. Following the completion of the sale, the insider now directly owns 8,960 shares of the company’s stock, valued at approximately $777,728. The disclosure for this sale can be found here. Insiders have sold 143,152 shares of company stock worth $12,095,954 in the last three months. Insiders own 27.80% of the company’s stock.
A number of research firms have weighed in on ABC. ValuEngine upgraded AmerisourceBergen from a “sell” rating to a “hold” rating in a report on Thursday, January 31st. UBS Group started coverage on AmerisourceBergen in a research report on Thursday, January 17th. They set a “buy” rating and a $89.00 price target on the stock. TheStreet downgraded AmerisourceBergen from a “b-” rating to a “c+” rating in a research report on Tuesday, January 8th. Zacks Investment Research raised shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a research note on Monday, January 7th. Finally, Barclays reissued a “hold” rating and set a $84.00 target price on shares of AmerisourceBergen in a research note on Sunday, January 6th. Seven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $96.00.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Further Reading: Balance Sheet
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.